Explore more publications!

Press Releases

U.S. Energy Corp. Signs Five-Year Helium Offtake Agreement with Investment-Grade Global Leader in Industrial Gases
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
Safe Pro to Demonstrate AI-Powered Mission Planning at U.S. Army Fort Leonard Wood Maneuver Support Center of Excellence Event
Neal Davis Law Firm Report Reveals Hidden Legal Risks in Age of Consent Laws Across All 50 States
Ingantec Joins UCSB’s Prestigious SSLEEC Consortium to Accelerate GaN and MicroLED Innovations
Stanley Steemer Gives Moms What They Really Want This Mother’s Day: A Professional Deep Clean
Recognized for Best Use of Tech in HR, Vetty Wins Bronze Stevie® in 2026 American Business Awards®
The Children’s Place Announces Strategic Partnership with  Al Othaim to Re-Enter Saudi Arabian Market
Court Reminder: Camping World May 11 Legal Deadline in Securities Class Action is Approaching – Investors with Losses Urged to Contact BFA Law
Portnoy Law Firm Announces Class Action on Behalf of Lufax Holding, Ltd. Investors
Portnoy Law Firm Announces Class Action on Behalf of Super Micro Computer, Inc. Investors
Court Reminder: Eos Energy May 5 Legal Deadline in Securities Class Action is Approaching – Investors with Losses Urged to Contact BFA Law
Court Reminder: Driven Brands May 8 Legal Deadline in Securities Class Action is Approaching – Investors with Losses Urged to Contact BFA Law
Momentive Software Earns Two Stevie® Awards in the 24th Annual American Business Awards®
$SRAD Stock: Sportradar Group Securities Fraud Investigation is Ongoing – Investors with Losses Urged to Contact BFA Law
Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm
Portnoy Law Firm Announces Class Action on Behalf of Pinterest, Inc. Investors
Embargoed Technical Briefing: Canada's Top Moonshot Ventures™ of 2026 Announced at NACO Summit
KBR’s Mission Technology Solutions Awarded $200 Million to Accelerate Safer, Smarter US Transportation Systems
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions